Gandhi, N.R., Shah, N.S., Andrews, J.R., Vella, V., Moll, A.P., Scott, M., et al. (2010) HIV Coinfection in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High Early Mortality. American Journal of Respiratory and Critical Care Medicine [Internet], 181, 80-86.
http://www.ncbi.nlm.nih.gov/pubmed/19833824

has been cited by the following article:

• TITLE: When Does Drug Resistant TB Strike HIV/TB Patients?—A South India Experience

  AUTHORS: Suresh Shastri, Sharath Burugina Nagaraja, Jaya Prasad Tripathy, Anil Singarajipur, Bharat Bhushan Rewari

  KEYWORDS: HIV, DR-TB, Outcomes, Duration

  JOURNAL NAME: World Journal of AIDS, Vol.7 No.1, March 13, 2017

  ABSTRACT: Background: India is a high TB (tuberculosis) burden country. The advent of HIV (Human immunodeficiency virus) and DR-TB (drug resistant TB) has worsened the ongoing TB control efforts. A study was conducted to (a) to determine the duration for developing drug resistant TB after diagnosis of HIV (b) to ascertain the patients status after one year of DR-TB treatment in Karnataka, India. Methods: It is a retrospective cross-sectional study involving review of records and reports at ART (Anti-retroviral treatment) centres and DR-TB centres in Karnataka during the period 2013-2014. Results: The median time from being known as HIV positive to being diagnosed as DR-TB was 1168 days (IQR: 571 - 1955). At the end of 14 months, nearly 39% of patients had died and 49% of patients were on treatment. Conclusion: The National Health programmes should prioritize monitoring of the HIV/TB patients and develop appropriate novel strategies for community involvement.